Zobrazeno 1 - 10
of 6 116
pro vyhledávání: ''
Autor:
Ya-Nan Jin, Qian-Qiong Yang, Tia Marks, Wangjian Zhang, Zi-Qian Li, Ji-Jin Yao, Liang-Ping Xia, Xue-Qing Ou
Publikováno v:
Radiotherapy and Oncology. 166:118-125
Purpose To quantify and predict the survival benefits of cumulative cisplatin dose during concurrent chemoradiotherapy (CC-CCD) in children and adolescents with locoregionally advanced nasopharyngeal carcinoma (CA-LANPC). Materials and Methods Patien
Autor:
Alan W. Katz, Alexandra Napieralska, Donald B. Fuller, Abigail Pepin, Xue Wu, D. Andrew Loblaw, Leszek Miszczyk, Sean P. Collins, Jeremie Calais, R. Philipson, Shrinivasa K. Upadhyaya, Rachel Glicksman, Matthew Rettig, Mark K. Buyyounouski, Amar U. Kishan, Paul C. Boutros, Constantine Mantz, Nicholas G. Nickols, Ming Wang, Hilary P. Bagshaw, Agnieska Namysł-Kaletka, Simeng Suy, Soumyajit Roy, Michael L. Steinberg, Nima Aghdam, N.G. Zaorsky, Ting Martin Ma
Publikováno v:
Radiotherapy and Oncology. 166:1-7
The Phoenix definition for biochemical failure (BCF) after radiotherapy uses nadir PSA (nPSA) + 2 ng/mL to classify a BCF and was derived from conventionally fractionated radiotherapy, which produces significantly higher nPSAs than stereotactic body
Autor:
John Iafrate, Florence K. Keane, C. Bowes, Justin F. Gainor, Vivek Naranbhai, Henning Willers, Kerri St. Denis, Alejandro B. Balazs, Evan C. Lam, Brittany Y Bertaux, Melin J. Khandekar
Publikováno v:
Radiotherapy and Oncology
The immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy is unknown. This prospective cohort study demonstrates that anti-SARS-CoV-2 spike antibody and neutralization titers are reduced in a subset of thoracic radiotherapy
Autor:
Claus Rödel, Paige L. Nitsch, Ramez Kouzy, M.F. McAleer, Emmanouil Fokas, Roshal R. Patel, Anuja Jhingran, Cullen M. Taniguchi, Albert C. Koong, Bruce D. Minsky, Rebecca M. Howell, Stephen F Kry, Prajnan Das, Ethan B. Ludmir, Kelsey L. Corrigan, C. David Fuller, Joseph Abi Jaoude
Publikováno v:
Radiother Oncol
Purpose Quality assurance (QA) practices improve the quality level of oncology trials by ensuring that the protocol is followed and the results are valid and reproducible. This study investigated the utilization of QA among randomized controlled tria
Autor:
Scott Glaser, Nayana Vora, Catheryn M. Yashar, Eric Radany, Chirag Shah, Arya Amini, Jason Liu, Colton Ladbury, Sushil Beriwal
Publikováno v:
Radiotherapy and Oncology. 166:79-87
PURPOSE To examine recent modality utilization trends in accelerated partial breast irradiation (APBI) in the National Cancer Database (NCDB) based on the American Society for Radiation Oncology (ASTRO) guidelines. MATERIALS AND METHODS A total of 58
Autor:
Shinji Tanaka, Shiro Oka, Ikuno Nishibuchi, Nobuki Imano, Yuki Takeuchi, Yuji Murakami, Yasushi Nagata, Yuji Urabe, Katsumaro Kubo
Publikováno v:
Radiotherapy and Oncology. 166:65-70
Background and purpose Radiotherapy (RT) has recently received increasing attention as an additional treatment for organ preservation after non-curative endoscopic submucosal dissection (ESD) in patients with superficial esophageal cancer. Esophageal
Autor:
Rui Zhao, Ran-Ling Wang, Shang-Zhi Hu, Xi Chen, Sheng-Ping Li, Ling-Xiao Zhou, Zhen-Ming Zhang, Yu Bao, Wu-Song Liu
Publikováno v:
Radiotherapy and Oncology. 165:14-19
Background Recurrence of nasopharyngeal carcinoma (NPC) after chemoradiotherapy is common, but submucosal recurrence of NPC is rare. The final pathological results determine the optimal therapeutic schedule for treatment of NPC recurrence, but tissue
Autor:
Beryl McCormick, G. Del Rosario, Lior Z. Braunstein, H.K. Tsai, Pamela Fox, Dennis Mah, J. Mamary, Simon N. Powell, Erin F. Gillespie, Haoyang Liu, I.J. Choi, Oren Cahlon, Atif J. Khan
Publikováno v:
Radiother Oncol
Purpose/Objective(s) Local breast cancer recurrences and new primary breast cancers are an increasingly common clinical challenge without clear treatment guidelines. To date, photon reirradiation (reRT) has not been widely adopted due to concerns for
Autor:
Benjamin H. Kann, Raymond H. Mak, Lisa Singer, Kailan Sierra-Davidson, David Kozono, Abby White, Kevin X. Liu, Kevin Tyan, Lawrence T. Orlina, J. Paul Marcoux
Publikováno v:
Radiother Oncol
BackgroundTrimodality therapy (TMT) with preoperative chemoradiation followed by surgical resection is used for locally-advanced non-small-cell lung cancer (LA-NSCLC). Traditionally, preoperative radiation doses ≤54Gy are used due to concerns regar
Publikováno v:
Radiotherapy and Oncology. 165:174-178
To compare long-term outcomes of high-grade, primary soft-tissue-sarcoma (STS), using Ifosfamide-Doxorubicin vs local therapy alone, in histology-specific sarcomas.Retrospective analysis was performed on 127 patients from 2005 to 2018, with high-grad